SCHEMBL6726013

SCHEMBL6726013

O=S(=O)(Cc1ccc(-c2ncccc2-c2ccc(Br)c(Br)c2)cc1F)Cc1ccc(-c2ncccc2-c2ccc(Br)c(Br)c2)cc1F

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FEN1 P39748 10/20 0.38
ALOX5AP P20292 8/20 0.37
KMO O15229 1/20 0.37
CDC25B P30305 1/20 0.37
PTGS2 P35354 2/20 0.36
PTGS1 P23219 1/20 0.36
TDP2 O95551 1/20 0.35
NSD2 O96028 1/20 0.35
ABL1 P00519 1/20 0.35
PLCG1 P19174 1/20 0.35
CES1 P23141 1/20 0.35
PAX8 Q06710 1/20 0.35
RIN1 Q13671 1/20 0.35
IDO1 P14902 1/20 0.34
PADI1 Q9ULC6 1/20 0.34
PADI3 Q9ULW8 1/20 0.34
PADI4 Q9UM07 1/20 0.34
PADI2 Q9Y2J8 1/20 0.34
TGFBR1 P36897 1/20 0.34
CA1 P00915 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6723308 0.90 KMO (0.39) FEN1ALOX5APKMOCDC25BPTGS2
SCHEMBL6722015 0.90 FEN1 (0.37) FEN1ALOX5APKMOCDC25BPTGS2
SCHEMBL6722643 0.89 PTGS2 (0.41) FEN1ALOX5APKMOCDC25BPTGS2
SCHEMBL6718600 0.88 GLO1 (0.42) FEN1ALOX5APKMOPTGS2PTGS1
SCHEMBL6725915 0.87 FEN1 (0.39) FEN1ALOX5APKMOCDC25BPTGS2
SCHEMBL6721925 0.87 CDC25B (0.38) FEN1ALOX5APKMOCDC25BPTGS2
SCHEMBL6726098 0.85 PTGS2 (0.42) FEN1ALOX5APKMOPTGS2PTGS1
SCHEMBL6721604 0.85 PTGS2 (0.51) FEN1ALOX5APKMOPTGS2PTGS1
SCHEMBL6723509 0.85 FEN1 (0.40) FEN1ALOX5APKMOPTGS2PTGS1
SCHEMBL6730237 0.85 FEN1 (0.41) FEN1ALOX5APKMOPTGS2PTGS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040092552-A1 2-Fluorobenzenesulfonyl compounds for the treatment of inflammation PHARMACIA CORPORATION 2004-05-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040092552-A1 2-Fluorobenzenesulfonyl compounds for the treatment of inflammation FPR2, PTGES2, FPR1 FEN1 1713/4885ALOX5AP 395/4885KMO 675/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.